Vulnerability Details : CVE-2023-33364
An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
Products affected by CVE-2023-33364
- cpe:2.3:a:supremainc:biostar_2:*:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2023-33364
0.09%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 40 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2023-33364
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
8.8
|
HIGH | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
2.8
|
5.9
|
NIST |
CWE ids for CVE-2023-33364
-
The product constructs all or part of an OS command using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the intended OS command when it is sent to a downstream component.Assigned by: nvd@nist.gov (Primary)
References for CVE-2023-33364
-
https://claroty.com/team82/disclosure-dashboard/cve-2023-33364
CVE-2023-33364 | ClarotyThird Party Advisory
-
https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291
Version 2.9.1 (V2.9.1.25) []Release Notes;Vendor Advisory
Jump to